Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

Today, Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets engineered to evade the immune system is producing insulin without immunosuppression. Learn more here:

Breakthrough T1D

62,738 subscribers

62,073 views • 1 year ago •via X (Twitter)

Science & Technology News & Politics Health & Wellness

Anya Rossi• Live Now

Private livecam show

10 Comments

Simon P1 year ago

This is such encouraging news for the T1D community. It's great to see progress in this area, and the work being done is very promising. I hope this leads to even more breakthroughs.

Celt Naturals1 year ago

Cold and Flu season getting you down? Immuno-Care can help your immune system work at peak performance. Our Health Canada approved natural health supplement is the best on the market and made in Canada. 7 key ingredients all specially coated to bypass harsh stomach acids.

john callinan1 year ago

The last piece of the puzzle is becoming a reality. Thank you BT1D.

Mary Singh1 year ago

Great news, great work BT1D. 👍💙

Jim Banting1 year ago

Maybe one day closer to extinguishing the Flame of Hope.

Namita1 year ago

What are the next steps? How far is this from becoming a cure for T1D?

Don Goldstein1 year ago

This is huge!

Sahas Mehra1 year ago

Congratulations! Can anyone please share a link to the paper? Trying to find it.

Karen B1 year ago

@1derfultype This is absolutely fantastic news.

mehmetali KUTLU1 year ago

How old did you use it?

Related Videos

Earlier today at the ADA Scientific Sessions, Sana Biotechnology gave an exciting 6-month update on the first person who received transplanted donor-derived pancreatic islet cells modified with hypo-immune (HIP) technology, a cell therapy that does NOT require immunosuppression. Breakthrough T1D’s Vice President of Research, Esther Latres, Ph.D., gives an update on this incredibly exciting step toward cures for type 1 diabetes (T1D).

Earlier today at the ADA Scientific Sessions, Sana Biotechnology gave an exciting 6-month update on the first person who received transplanted donor-derived pancreatic islet cells modified with hypo-immune (HIP) technology, a cell therapy that does NOT require immunosuppression. Breakthrough T1D’s Vice President of Research, Esther Latres, Ph.D., gives an update on this incredibly exciting step toward cures for type 1 diabetes (T1D).

Breakthrough T1D

14,131 views • 1 year ago

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:

Breakthrough T1D

42,636 views • 1 year ago

i saw this video today (first off why is tommyinnit here), and realised even people with friends who have type 1 diabetes aren’t aware of certain medical devices, so here is your guide to T1D devices that you may see in public!!

i saw this video today (first off why is tommyinnit here), and realised even people with friends who have type 1 diabetes aren’t aware of certain medical devices, so here is your guide to T1D devices that you may see in public!!

jess :D

99,669 views • 4 months ago

On Friday, the FDA expanded its approved use of Afrezza for kids six years and older who have Type 1 diabetes or those who require insulin with Type 2 diabetes — making it the first ever needle-free insulin option for pediatric patients, according to MannKind Corporation.

On Friday, the FDA expanded its approved use of Afrezza for kids six years and older who have Type 1 diabetes or those who require insulin with Type 2 diabetes — making it the first ever needle-free insulin option for pediatric patients, according to MannKind Corporation.

ABC News

25,784 views • 4 months ago

A medical breakthrough is showing promise for millions of Americans with Type 1 diabetes. It's an alternative to taking insulin without the injections.

A medical breakthrough is showing promise for millions of Americans with Type 1 diabetes. It's an alternative to taking insulin without the injections.

CBS Evening News with Tony Dokoupil

10,868 views • 4 months ago

It’s official! We are now Breakthrough T1D UK 🎉 As Breakthrough T1D we’ll continue the journey we started as JDRF: 💙 driving breakthroughs towards a world without type 1 diabetes 💙 helping make every day better for the people who face type 1 💙 working to give everyone with T1D access to the best treatment and support We can’t do any of this without your incredible support. Thank you. Together, let’s make a world where no one lives with T1D. Find out more about our work: #Type1Diabetes #T1D #GBDoc

It’s official! We are now Breakthrough T1D UK 🎉 As Breakthrough T1D we’ll continue the journey we started as JDRF: 💙 driving breakthroughs towards a world without type 1 diabetes 💙 helping make every day better for the people who face type 1 💙 working to give everyone with T1D access to the best treatment and support We can’t do any of this without your incredible support. Thank you. Together, let’s make a world where no one lives with T1D. Find out more about our work: #Type1Diabetes #T1D #GBDoc

Breakthrough T1D UK

22,980 views • 2 years ago

27 years ago I was diagnosed with Type 1 Diabetes. TODAY I AM RELEASING MY BOOK ABOUT THE DAILY BATTLE WITH THIS DISEASE, THE FEARLESS DIABETIC. It’s my goal to educate the world on the highs and lows of T1D. Click below to purchase and learn more.

27 years ago I was diagnosed with Type 1 Diabetes. TODAY I AM RELEASING MY BOOK ABOUT THE DAILY BATTLE WITH THIS DISEASE, THE FEARLESS DIABETIC. It’s my goal to educate the world on the highs and lows of T1D. Click below to purchase and learn more.

Ben Milsom

19,132 views • 2 years ago

VIDEO | Type-2 Diabetes to benefit most from weekly insulin; Type-1 Diabetics still require meal-time insulin, says endocrinologist Dr. Ambrish Mithal. Explaining the potential impact of once-weekly insulin, endocrinologist Dr. Ambrish Mithal (Dr Ambrish Mithal) says, "Replacing one insulin injection a day with one injection a week means reducing the number of injections from 365 to 52 a year. That is a significant difference and a major step forward for people with Type 2 diabetes. It can also be used in people with Type 1 diabetes, but they will still require short-acting insulin injections before each meal. Type 1 diabetes cannot be managed with basal insulin alone. As for gestational diabetes, it is not approved for use at the moment. There is nothing inherently negative about the therapy during pregnancy, but it has not yet been approved for that indication." #WeeklyInsulin #Awiqli #Type2Diabetes #Type1Diabetes #BasalInsulin #GestationalDiabetes #DiabetesCare #Healthcare (Full video available on PTI Videos -

VIDEO | Type-2 Diabetes to benefit most from weekly insulin; Type-1 Diabetics still require meal-time insulin, says endocrinologist Dr. Ambrish Mithal. Explaining the potential impact of once-weekly insulin, endocrinologist Dr. Ambrish Mithal (Dr Ambrish Mithal) says, "Replacing one insulin injection a day with one injection a week means reducing the number of injections from 365 to 52 a year. That is a significant difference and a major step forward for people with Type 2 diabetes. It can also be used in people with Type 1 diabetes, but they will still require short-acting insulin injections before each meal. Type 1 diabetes cannot be managed with basal insulin alone. As for gestational diabetes, it is not approved for use at the moment. There is nothing inherently negative about the therapy during pregnancy, but it has not yet been approved for that indication." #WeeklyInsulin #Awiqli #Type2Diabetes #Type1Diabetes #BasalInsulin #GestationalDiabetes #DiabetesCare #Healthcare (Full video available on PTI Videos -

Press Trust of India

24,580 views • 3 months ago

Today, celebrated Raksha Bandhan with girls suffering from Type 1 diabetes in Ahmedabad, Gujarat. The Modi govt is extending its protective care to children living with this condition across the country by providing them with lifelong access to free insulin.

Today, celebrated Raksha Bandhan with girls suffering from Type 1 diabetes in Ahmedabad, Gujarat. The Modi govt is extending its protective care to children living with this condition across the country by providing them with lifelong access to free insulin.

Amit Shah

757,272 views • 1 month ago

🔊Sound on!🔊 We're excited to introduce our new film, ‘What a cure feels like’, celebrating our transformation to Breakthrough T1D! The film features real people affected by type 1 diabetes (T1D) and captures the relentless nature of living with T1D and the hundreds of extra decisions made each day. We would like to say a special thank you to Tara humphrey and her daughter Tahlia, LiS Warren 💙, Joe and his partner Salman and Jon Peach who shared their experiences and worked alongside us to create this film. Together, let's raise awareness and inspire hope for a future without T1D💙 #BreakthroughT1D #WhatACureFeelsLike #T1D #GBDoc

🔊Sound on!🔊 We're excited to introduce our new film, ‘What a cure feels like’, celebrating our transformation to Breakthrough T1D! The film features real people affected by type 1 diabetes (T1D) and captures the relentless nature of living with T1D and the hundreds of extra decisions made each day. We would like to say a special thank you to Tara humphrey and her daughter Tahlia, LiS Warren 💙, Joe and his partner Salman and Jon Peach who shared their experiences and worked alongside us to create this film. Together, let's raise awareness and inspire hope for a future without T1D💙 #BreakthroughT1D #WhatACureFeelsLike #T1D #GBDoc

Breakthrough T1D UK

110,119 views • 1 year ago

Today, more than 170 delegates from all 50 states and five countries were in Washington for the 2025 Breakthrough Type 1 Diabetes Children’s Congress. I was proud to chair a Senate Appropriations Committee hearing to welcome the delegates and focus on the importance of federal investment in Type 1 diabetes research. Senator Jeanne Shaheen and I — the founding co-chairs of the bipartisan Senate Diabetes Caucus — introduced legislation this week to reauthorize the Special Diabetes Program, a federal initiative that provides $160 million annually for Type 1 diabetes research and prevention. Thanks to this program and the tireless advocacy of Breakthrough T1D and its Children’s Congress Delegates, we are seeing life changing breakthroughs in the fight against this terrible disease. Some of these developments include the now widely used continuous glucose monitors, the first FDA-approved artificial pancreas, and a groundbreaking clinical trial in which 10 of the 12 participants no longer need insulin to manage their diabetes because of a stem cell-based therapy. Since the founding of the Senate Diabetes Caucus in 1997, federal funding for diabetes research has increased from $319 million to more than $2.3 billion annually. I want to thank our outstanding witnesses for today’s hearing: Ruby Whitmore of Old Town, Maine, Rachel White of North Hampton, New Hampshire, Katie Bone of Bernalillo, New Mexico, and Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Their passionate testimony highlighted both the daily realities of living with type 1 diabetes and the vital role of continued federal research through agencies like the NIDDK. Finding a cure for Type 1 diabetes remains our ultimate goal and has been one of my highest priorities since the very beginning of my Senate service. With continued advocacy, bipartisan support, and strong federal investment, I am confident that day will come.

Today, more than 170 delegates from all 50 states and five countries were in Washington for the 2025 Breakthrough Type 1 Diabetes Children’s Congress. I was proud to chair a Senate Appropriations Committee hearing to welcome the delegates and focus on the importance of federal investment in Type 1 diabetes research. Senator Jeanne Shaheen and I — the founding co-chairs of the bipartisan Senate Diabetes Caucus — introduced legislation this week to reauthorize the Special Diabetes Program, a federal initiative that provides $160 million annually for Type 1 diabetes research and prevention. Thanks to this program and the tireless advocacy of Breakthrough T1D and its Children’s Congress Delegates, we are seeing life changing breakthroughs in the fight against this terrible disease. Some of these developments include the now widely used continuous glucose monitors, the first FDA-approved artificial pancreas, and a groundbreaking clinical trial in which 10 of the 12 participants no longer need insulin to manage their diabetes because of a stem cell-based therapy. Since the founding of the Senate Diabetes Caucus in 1997, federal funding for diabetes research has increased from $319 million to more than $2.3 billion annually. I want to thank our outstanding witnesses for today’s hearing: Ruby Whitmore of Old Town, Maine, Rachel White of North Hampton, New Hampshire, Katie Bone of Bernalillo, New Mexico, and Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Their passionate testimony highlighted both the daily realities of living with type 1 diabetes and the vital role of continued federal research through agencies like the NIDDK. Finding a cure for Type 1 diabetes remains our ultimate goal and has been one of my highest priorities since the very beginning of my Senate service. With continued advocacy, bipartisan support, and strong federal investment, I am confident that day will come.

Sen. Susan Collins

12,387 views • 1 year ago

VIDEO | Talking about Novo Nordisk's newly launched once-weekly insulin, Awiqli, endocrinologist Dr. Ambrish Mithal(Dr Ambrish Mithal) says, "I think the idea of a once-weekly insulin injection to replace conventional daily basal insulin is a great one. It represents a significant advance in diabetes management worldwide. In chronic care, adherence is the most important factor. Patients need to take their medication consistently, and injectable therapies often become a barrier. Despite all our efforts, many Indians remain concerned about having to take a daily insulin shot when insulin therapy is initiated. A once-weekly injection will certainly improve patient acceptance of insulin initiation and make it more likely that they will adhere to treatment. I believe this is a major step forward in diabetes management, particularly for people with Type 2 diabetes who are starting basal insulin. It is important to remember, however, that insulin therapy may sometimes involve both basal insulin and prandial (meal-time) insulin. If meal-time insulin is required, it will still need to be administered separately." #Awiqli #WeeklyInsulin #Diabetes #Type2Diabetes #Type1Diabetes #InsulinTherapy #DiabetesCare #Healthcare (Full video available on PTI Videos -

VIDEO | Talking about Novo Nordisk's newly launched once-weekly insulin, Awiqli, endocrinologist Dr. Ambrish Mithal(Dr Ambrish Mithal) says, "I think the idea of a once-weekly insulin injection to replace conventional daily basal insulin is a great one. It represents a significant advance in diabetes management worldwide. In chronic care, adherence is the most important factor. Patients need to take their medication consistently, and injectable therapies often become a barrier. Despite all our efforts, many Indians remain concerned about having to take a daily insulin shot when insulin therapy is initiated. A once-weekly injection will certainly improve patient acceptance of insulin initiation and make it more likely that they will adhere to treatment. I believe this is a major step forward in diabetes management, particularly for people with Type 2 diabetes who are starting basal insulin. It is important to remember, however, that insulin therapy may sometimes involve both basal insulin and prandial (meal-time) insulin. If meal-time insulin is required, it will still need to be administered separately." #Awiqli #WeeklyInsulin #Diabetes #Type2Diabetes #Type1Diabetes #InsulinTherapy #DiabetesCare #Healthcare (Full video available on PTI Videos -

Press Trust of India

11,743 views • 3 months ago

Today, First Lady Melania Trump is unveiling a new enhanced, educational White House public tour for visitors. This is the first significant improvement to the tour in decades. The First Lady hopes the tour inspires everyone who visits the White House to learn more about our shared history.

Today, First Lady Melania Trump is unveiling a new enhanced, educational White House public tour for visitors. This is the first significant improvement to the tour in decades. The First Lady hopes the tour inspires everyone who visits the White House to learn more about our shared history.

Karine Jean-Pierre Archived

162,729 views • 2 years ago

🚨🚨🚨🚨 LOW CARB IS FINALLY THE LAW OF THE LAND FOR TYPE 1 DIABETES! New publication details the first major medical society endorsement of therapeutic carb reduction (TCR) for T1D! Here's coauthor Dave Dikeman with a two-minute summary of the revolution in T1D care from SMHP. ALL people with Type 1 deserve the choice to normalize their blood glucose and avoid the complications from high blood glucose. Dr. Eric Westman, MD, MHS Robert Cywes MD Laura Buchanan MD, MHP Matt Calkins MD MHP T1D Nutrition Miriam Kalamian Ian Lake Dr Evelyne Bourdua-Roy Doug Reynolds, MHP Michael Fitzpatrick Dr. Ryan Attar Andrew Koutnik, Ph.D.

🚨🚨🚨🚨 LOW CARB IS FINALLY THE LAW OF THE LAND FOR TYPE 1 DIABETES! New publication details the first major medical society endorsement of therapeutic carb reduction (TCR) for T1D! Here's coauthor Dave Dikeman with a two-minute summary of the revolution in T1D care from SMHP. ALL people with Type 1 deserve the choice to normalize their blood glucose and avoid the complications from high blood glucose. Dr. Eric Westman, MD, MHS Robert Cywes MD Laura Buchanan MD, MHP Matt Calkins MD MHP T1D Nutrition Miriam Kalamian Ian Lake Dr Evelyne Bourdua-Roy Doug Reynolds, MHP Michael Fitzpatrick Dr. Ryan Attar Andrew Koutnik, Ph.D.

RD, Ph.D.

13,593 views • 1 year ago

Spent the evening with children who have type 1 diabetes organised by Diabetes Association of Pakistan. It is not easy for children to live a life without meetha nor is it fair but such is life. As a fellow diabetic myself, I have invited the children to my office for a sugar free dessert treat. Looking forward to hosting the children ❤️

Spent the evening with children who have type 1 diabetes organised by Diabetes Association of Pakistan. It is not easy for children to live a life without meetha nor is it fair but such is life. As a fellow diabetic myself, I have invited the children to my office for a sugar free dessert treat. Looking forward to hosting the children ❤️

Murtaza Wahab Siddiqui

11,878 views • 1 month ago

We're just getting started with all the cool new stuff this is going to unlock! I became the first person to fly a pelican on Halo 1 without mods today :)

We're just getting started with all the cool new stuff this is going to unlock! I became the first person to fly a pelican on Halo 1 without mods today :)

Monopoli

40,044 views • 2 years ago

Our medical research system, AMIE, is the first patient-facing conversational diagnostic tool of its kind to be studied prospectively in a real-world clinical setting. In a study, published today in The Lancet, we found that when patients chatted with AMIE before an in-person appointment, the interaction built their confidence and helped them organize their thoughts. And physicians who reviewed the information from the patient conversation got more time back to focus on collaborative care and shared decision-making instead of digging through data.

Our medical research system, AMIE, is the first patient-facing conversational diagnostic tool of its kind to be studied prospectively in a real-world clinical setting. In a study, published today in The Lancet, we found that when patients chatted with AMIE before an in-person appointment, the interaction built their confidence and helped them organize their thoughts. And physicians who reviewed the information from the patient conversation got more time back to focus on collaborative care and shared decision-making instead of digging through data.

Google

141,212 views • 5 days ago

What we're unveiling today is something a lot of people have been asking about : Rental system! 1) With the rental system, you can lend the spare horses to someone else, and the person who has rented the horse can play the completely Free to Play!!

What we're unveiling today is something a lot of people have been asking about : Rental system! 1) With the rental system, you can lend the spare horses to someone else, and the person who has rented the horse can play the completely Free to Play!!

Sean Hahm

13,783 views • 3 years ago